Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry-Reference-Cited by-同舟云学术

Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry

Published:2018-07-06 Issue:7 Volume:76 Page:1064-1072
ISSN:1897-4279
Container-title:Kardiologia Polska
language:
Short-container-title:Kardiol Pol

Author:

Migaj Jacek,Kałużna-Oleksy Marta,Nessler Jadwiga,Opolski Grzegorz,Crespo-Leiro Marisa G.,Maggioni Aldo P.,Grajek Stefan,Ponikowski Piotr,Drożdż Jarosław,Straburzyńska-Migaj Ewa

Publisher

Polskie Towarzystwo Kardiologiczne

Subject

Cardiology and Cardiovascular Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of betablockers and digoxin in black African heart failure patients based on a non-interventional cohort study at Abidjan Heart Institute;African Journal of Pharmacy and Pharmacology;2024-07-31

2. Digoxin and Outcomes in Patients with Heart Failure and Preserved Ejection Fraction (HFpEF) Patients: A Systematic Review and Meta- Analysis;Current Drug Targets;2023-02

3. Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment;European Journal of Heart Failure;2020-02

4. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice;Pharmacological Research;2019-08

5. Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update;The American Journal of Cardiology;2019-01